# Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

> **NCT01748838** · PHASE1 · COMPLETED · sponsor: **Celtaxsys, Inc.** · enrollment: 96 (actual)

## Conditions studied

- Pulmonary Inflammation

## Interventions

- **DRUG:** CTX-4430
- **OTHER:** Mannitol
- **DRUG:** Placebo
- **DRUG:** CTX-4430
- **DRUG:** Placebo
- **OTHER:** Mannitol

## Key facts

- **NCT ID:** NCT01748838
- **Lead sponsor:** Celtaxsys, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2013-09-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748838, "Phase 1 Study Assessing the Safety and Tolerability of CTX-4430". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01748838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*